The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C

by Preveden Tomislav, Ružić Maja, Pete Maria
Published 2017-01-01

Risk factors for recurrent Clostridium difficile infection among patients in the Clinical Centre of Vojvodina, Serbia: A retrospective clinical trial

by Kovačević Nadica, Doder Radoslava, Preveden Tomislav, Pete Maria
Published 2019-01-01

The occurrence of liver steatosis in patients with chronic hepatitis C - the experience of the Clinical Center of Vojvodina

by Preveden Tomislav, Ružić Maja, Kovačević Nadica, Pete Maria, Fabri Milotka
Published 2018-01-01

Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with Pegylated interferon alfa-2a and ribavirin

by Fabri Milotka, Ružić Maja, Lendak Dajana, Preveden Tomislav, Fabri Izabela, Petrić Vedrana
Published 2013-01-01

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy

by Ružić Maja, Fabri Milotka, Preveden Tomislav, Bačulov Katarina, Pete Maria, Stojšin Anja
Published 2018-01-01

Treatment of chronic hepatitis C among injecting drug users: A 5-year follow-up

by Ruzić Maja, Fabri Milotka, Preveden Tomislav, Kiralj Katarina, Mikić Stefan Sandra, Vukadinov Tatjana
Published 2013-01-01